Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age. [electronic resource]
- Pediatrics May 2009
- e770-6 p. digital
Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
1098-4275
10.1542/peds.2008-2945 doi
Adolescent Attention Deficit Disorder with Hyperactivity--complications Child Double-Blind Method Female Humans Hypnotics and Sedatives--administration & dosage Male Polysomnography Pyridines--administration & dosage Sleep Initiation and Maintenance Disorders--drug therapy Treatment Outcome Zolpidem